ArticleFrontiers in oncology2021

Corrigendum: Efficacy and Safety of CAR-T Cell Products Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel for the Treatment of Hematologic Malignancies: A Systematic Review and Meta-Analysis.

Jun Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.